Tetrandrine may treat membranous glomerulopathy via P13K/Akt signaling pathway regulation: therapeutic mechanism validation using Heymann nephritis rat model-Reference-Cited by-同舟云学术

Tetrandrine may treat membranous glomerulopathy via P13K/Akt signaling pathway regulation: therapeutic mechanism validation using Heymann nephritis rat model

Published:2021-01-01 Issue:1 Volume:12 Page:6499-6515
ISSN:2165-5979
Container-title:Bioengineered
language:en
Short-container-title:Bioengineered

Author:

Yin Jiazhen¹,Lin Jiazhen²,Yu Jin¹,Wei Xia³,Zhu Bin¹,Zhu Caifeng¹^ORCID

Affiliation:

1. Department of Nephrology, Hangzhou Tcm Hospital Affiliated of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

2. School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

3. Department of Gastroenterology, Hangzhou Tcm Hospital Affiliated of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China

Funder

Heymann nephritis rats

A prospective randomized controlled study on the treatment of idiopathic membranous nephropathy based on Zhu Caifeng’s “collateral disease theory” control study

Publisher

Informa UK Limited

Subject

Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21655979.2021.1973862

Reference47 articles.

1. Idiopathic membranous glomerulonephritis

2. Sanqi oral solution ameliorates renal damage and restores podocyte injury in experimental membranous nephropathy via suppression of NFκB

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effects of tetrandrine in inflammatory diseases: a comprehensive review;Inflammopharmacology;2024-04-03

2. Tetrandrine Alleviates Silica-induced Pulmonary Fibrosis Through PI3K/AKT Pathway: Network Pharmacology Investigation and Experimental Validation;Inflammation;2024-01-24

3. Network pharmacology and molecular docking predictions of the active compounds and mechanism of action of Huangkui capsule for the treatment of idiopathic membranous nephropathy;Medicine;2023-09-15

4. Identification of Hub Genes and Therapeutic Agents for IgA Nephropathy Through Bioinformatics Analysis and Experimental Validation;Frontiers in Medicine;2022-06-28

5. Network Pharmacology and In Vivo Experimental Validation to Uncover the Renoprotective Mechanisms of Fangji Huangqi Decoction on Nephrotic Syndrome;Evidence-Based Complementary and Alternative Medicine;2022-06-08